retatrutide lower blood pressure (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide, a new weight loss

We have lots of challenges every other montheverything from movement to the nervous system, nutrition, and so on

His daughter was diagnosed with a prolactinoma: a benign tumor of the pituitary gland that, left unchecked, can interfere with metabolism, leading to weight gain

In summary, findings presented herein have profound implications for patients currently considering or taking incretin mimetics for diabetes or weight loss on cancer outcomes

2011 Sep;28(7):292-

Experimental investigations have demonstrated that cholangiocytes are sensitive to GLP-1 and respond with augmented proliferation, potentially increasing the risk of duct obstruction [47,48]